These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8031406

  • 21. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC.
    N Engl J Med; 1996 Aug 08; 335(6):384-91. PubMed ID: 8663871
    [Abstract] [Full Text] [Related]

  • 22. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
    Craft JC, Notario GF, Grosset JH, Heifets LB.
    Clin Infect Dis; 1998 Oct 08; 27(4):807-12. PubMed ID: 9798037
    [Abstract] [Full Text] [Related]

  • 23. Rifabutin for MAC questioned.
    Posit Aware; 1995 Oct 08; ():6. PubMed ID: 11362571
    [Abstract] [Full Text] [Related]

  • 24. Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare.
    Zhang Z, Lu J, Du Y, Xie F, Wang Y, Sun B, Pang Y.
    J Glob Antimicrob Resist; 2019 Sep 08; 18():183-186. PubMed ID: 30953831
    [Abstract] [Full Text] [Related]

  • 25. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
    Heifets LB.
    Res Microbiol; 1994 Sep 08; 145(3):188-96. PubMed ID: 7809471
    [No Abstract] [Full Text] [Related]

  • 26. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex.
    Nash KA, Inderlied CB.
    Antimicrob Agents Chemother; 1996 Jul 08; 40(7):1748-50. PubMed ID: 8807078
    [Abstract] [Full Text] [Related]

  • 27. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
    Horgen L, Legrand E, Rastogi N.
    FEMS Immunol Med Microbiol; 1999 Jan 08; 23(1):37-44. PubMed ID: 10030545
    [Abstract] [Full Text] [Related]

  • 28. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL.
    Drugs; 1997 Jan 08; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [Abstract] [Full Text] [Related]

  • 29. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M, Fessel J, Kumar P, Dickenson G, Keiser P, Boulos M, Mogyros M, White AC, Cahn P, O'Connor M, Lewi D, Green S, Tilles J, Hicks C, Bissett J, Schneider MM, Benner R.
    Clin Infect Dis; 2000 Nov 08; 31(5):1245-52. PubMed ID: 11073759
    [Abstract] [Full Text] [Related]

  • 30. Susceptibility testing of Mycobacterium avium complex isolates.
    Heifets L.
    Antimicrob Agents Chemother; 1996 Aug 08; 40(8):1759-67. PubMed ID: 8843278
    [No Abstract] [Full Text] [Related]

  • 31. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC, Witt MD, Bozzette SA, McCutchan JA.
    N Engl J Med; 1996 Aug 08; 335(6):392-8. PubMed ID: 8676932
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
    Yajko DM.
    Res Microbiol; 1992 May 08; 143(4):411-9. PubMed ID: 1455069
    [No Abstract] [Full Text] [Related]

  • 33. Similar serovar and drug susceptibility profiles among AIDS-related Mycobacterium avium isolates from diverse geographic locations.
    Jacobs NJ, Fordham Von Reyn C, Gine N, Dawson D.
    Am J Med Sci; 1997 Jun 08; 313(6):352-4. PubMed ID: 9186150
    [Abstract] [Full Text] [Related]

  • 34. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG.
    Clin Infect Dis; 1998 Dec 08; 27(6):1401-5. PubMed ID: 9868650
    [Abstract] [Full Text] [Related]

  • 35. Clarithromycin against Mycobacterium avium complex infections.
    Heifets LB.
    Tuber Lung Dis; 1996 Feb 08; 77(1):19-26. PubMed ID: 8733409
    [Abstract] [Full Text] [Related]

  • 36. PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
    Hirama T, Shiono A, Egashira H, Kishi E, Hagiwara K, Nakamura H, Kanazawa M, Nagata M.
    J Clin Microbiol; 2016 Mar 08; 54(3):699-704. PubMed ID: 26739154
    [Abstract] [Full Text] [Related]

  • 37. Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium.
    Heifets LB, Lindholm-Levy PJ, Comstock RD.
    Antimicrob Agents Chemother; 1992 Aug 08; 36(8):1695-8. PubMed ID: 1416852
    [Abstract] [Full Text] [Related]

  • 38. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R.
    J Infect Dis; 2000 Apr 08; 181(4):1289-97. PubMed ID: 10762562
    [Abstract] [Full Text] [Related]

  • 39. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 08; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 40. Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
    Grosset J, Ji B.
    Drugs; 1997 May 08; 54 Suppl 2():23-7; discussion 28-9. PubMed ID: 9358197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.